Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Vor Biopharma Inc. VOR

Full chart Compare

Set alert

20.09 USD +0.53 (+2.71%)

At closeNov 11, 2026, 4:00 PM EST

20.09 0.00 0.00%

After hours · Nov 11, 4:00 PM ET

19.57 Day range 20.30

6.50 52-week range 26.00

YTD: +53.59%
1 year: +104.17%

News

1 day ago globenewswire.com Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will…
2 weeks ago benzinga.com Vor Bio Announces Final Two-Year Results From Phase 3 TELIGAN Trial Evaluating Telitacicept In Adults With Iga Nephropathy; TELIGAN Met Stage B Primary Endpoint Annualized eGFR slope of -0.6 vs. -5.7 mL/min/1.73 m²/year for placebo, a 5.1 mL/min/1.73 m²/year treatment difference (p<0.001)89% and 81% reductions in risk of confirmed ≥30% and ≥40% eGFR declines,